[{"name":"Panel discussion (ID 772)","mode":"","is_cme":false,"info":{"presentation":"Panel discussion <small>(ID 772)<\/small>","session":"MSD - Industry Satellite Symposium: The evolving treatment landscape of early triple negative breast cancer <small>(ID 74)<\/small>","presenter":"Sherko Kümmel<small> (Essen, Germany)<\/small>","photo":null},"playlist":[{"name":"Panel discussion","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/breast2020\/74\/v\/772_5c.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/breast2020\/74\/v\/772_5c.mp4","cover":"","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/breast2020\/74\/v\/772_5c.vtt","thumbnails":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/breast2020\/74\/v\/772_5c-thumbnails.vtt"}]}]{"provider":"CTI","provider_live":0,"type":1,"code":"8L240ej02Vk"}